患者特征和静脉注射免疫球蛋白（IVIG）产品特定机制都可能影响免疫球蛋白治疗的川崎病中的嗜酸性粒细胞。 - Suppr

Suppr

超能文献

Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.

作者信息

Khan S, Doré P C, Sewell W A C

出版信息

Pediatr Allergy Immunol. 2008 Mar;19(2):186-7. doi: 10.1111/j.1399-3038.2007.00658.x.

DOI:10.1111/j.1399-3038.2007.00658.x

PMID:18257907

Abstract

摘要

相似文献

Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.

Pediatr Allergy Immunol. 2008 Mar;19(2):186-7. doi: 10.1111/j.1399-3038.2007.00658.x.

Patient characteristics and intravenous immunoglobulin product may affect eosinophils in Kawasaki disease.

Pediatr Allergy Immunol. 2008 Mar;19(2):184-5. doi: 10.1111/j.1399-3038.2007.00657.x.

The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease.

Pediatr Allergy Immunol. 2007 Jun;18(4):354-9. doi: 10.1111/j.1399-3038.2007.00516.x.

Treatment of Kawasaki disease using locally product intravenous immunoglobulin.

J Med Assoc Thai. 2003 Aug;86 Suppl 3:S656-60.

Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease.

Pediatr Allergy Immunol. 2009 May;20(3):266-72. doi: 10.1111/j.1399-3038.2008.00779.x.

Hair loss as a sign of Kawasaki disease.

Iran J Allergy Asthma Immunol. 2006 Dec;5(4):199-200.

Lessons from Kawasaki disease: all brands of IVIG are not equal.

J Pediatr. 2006 Jan;148(1):6-8. doi: 10.1016/j.jpeds.2005.09.019.

Marked eosinophilia in a patient with history of severe atypical Kawasaki disease.

Congenit Heart Dis. 2013 Sep-Oct;8(5):E130-3. doi: 10.1111/j.1747-0803.2012.00696.x. Epub 2012 Aug 7.

[Immunoglobulin therapy].

Nihon Rinsho. 2014 Sep;72(9):1617-22.

Cardiology patient pages. Kawasaki disease.

Circulation. 2008 Aug 12;118(7):e110-2. doi: 10.1161/CIRCULATIONAHA.107.751404.

引用本文的文献

Comparative effectiveness of intravenous immunoglobulin from different manufacturing processes on Kawasaki disease.

World J Pediatr. 2014 May;10(2):114-8. doi: 10.1007/s12519-014-0479-8. Epub 2014 May 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.

作者信息

Khan S, Doré P C, Sewell W A C

出版信息

Pediatr Allergy Immunol. 2008 Mar;19(2):186-7. doi: 10.1111/j.1399-3038.2007.00658.x.

DOI:10.1111/j.1399-3038.2007.00658.x

PMID:18257907

Abstract

摘要

相似文献

Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.

Pediatr Allergy Immunol. 2008 Mar;19(2):186-7. doi: 10.1111/j.1399-3038.2007.00658.x.

Patient characteristics and intravenous immunoglobulin product may affect eosinophils in Kawasaki disease.

Pediatr Allergy Immunol. 2008 Mar;19(2):184-5. doi: 10.1111/j.1399-3038.2007.00657.x.

The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease.

Pediatr Allergy Immunol. 2007 Jun;18(4):354-9. doi: 10.1111/j.1399-3038.2007.00516.x.

Treatment of Kawasaki disease using locally product intravenous immunoglobulin.

J Med Assoc Thai. 2003 Aug;86 Suppl 3:S656-60.

Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease.

Pediatr Allergy Immunol. 2009 May;20(3):266-72. doi: 10.1111/j.1399-3038.2008.00779.x.

Hair loss as a sign of Kawasaki disease.

Iran J Allergy Asthma Immunol. 2006 Dec;5(4):199-200.

Lessons from Kawasaki disease: all brands of IVIG are not equal.

J Pediatr. 2006 Jan;148(1):6-8. doi: 10.1016/j.jpeds.2005.09.019.

Marked eosinophilia in a patient with history of severe atypical Kawasaki disease.

Congenit Heart Dis. 2013 Sep-Oct;8(5):E130-3. doi: 10.1111/j.1747-0803.2012.00696.x. Epub 2012 Aug 7.

[Immunoglobulin therapy].

Nihon Rinsho. 2014 Sep;72(9):1617-22.

Cardiology patient pages. Kawasaki disease.

Circulation. 2008 Aug 12;118(7):e110-2. doi: 10.1161/CIRCULATIONAHA.107.751404.

引用本文的文献

Comparative effectiveness of intravenous immunoglobulin from different manufacturing processes on Kawasaki disease.

World J Pediatr. 2014 May;10(2):114-8. doi: 10.1007/s12519-014-0479-8. Epub 2014 May 7.